A congressional subcommittee is seeking a government probe of a $646 million contract that was awarded in April to the parent company of Philips Respironics for hospital ventilators.

The House Subcommittee on Economic and Consumer Policy is seeking an investigation by the Inspector General into the contract awarded by the U.S. Department of Health and Human Services to supply the Strategic National Stockpile, the nation’s medical reserve.

The contract was cut short, with less than one-fourth of the order delivered, because the agreement was undergoing an internal HHS investigation and legal review, an HHS spokeswoman said Monday. Details of the review were not disclosed.

On July 31, the subcommittee released the findings of its investigation, which allegedly uncovered “fraud, waste and abuse” in the contract. The subcommittee claimed that the U.S. paid Philips more than four times the amount of the previous contract with the company for a functionally identical product, resulting in a loss to taxpayers as high as $504 million.

Advertise with us

“No other U.S. purchaser paid more than HHS,” subcommittee chairman Raja Krishnamoorthi wrote to the HHS inspector general Aug. 6. “Despite buying ventilators in bulk, the administration paid $15,000 per ventilator, while small purchasers across the country negotiated much better deals.”

Royal Philips CEO Frans van Houten denied the claims, saying the company had fully complied with the subcommittee’s request for information about Philips’ government contracts.

“We do not recognize the conclusions in the subcommittee’s report and we believe that not all of the information that we provided has been reflected in the report,” he wrote in a July 31 response. “I would like to make clear that at no occasion, Philips has raised prices to benefit from the crisis situation.”

The company’s ventilators had a list price exceeding $21,000, which were being sold to HHS at a discounted price of $15,000 to reflect higher costs related to the government’s expedited delivery requirements, Mr. van Houten wrote. The subcommittee said the units could be purchased at still lower prices.

Previously, the company built 10,000 ventilators for HHS’ Biomedical Advanced Research and Development Authority at a “price considerably lower than commercial prices,” Philips said, but that agreement was “chiefly a research and development contract.”

Advertise with us

Along with the recent Philips contract, HHS terminated two other contracts with ventilator makers earlier than planned, although for different reasons. Vyaire Medical Inc., of Chicago, and Hamilton Medical Inc., of Reno, Nev., both had supply contracts cut short, according to HHS, because the department believed the national stockpile was fully supplied to handle a future emergency.

The government had contracted with different companies to make what was then described as more than 187,000 ventilators by the end of the year.

The early endings of the contracts will reduce by 38,000 the number of ventilators scheduled for delivery to the Strategic National Stockpile by the end of the year, “saving the U.S. taxpayer millions of dollars by halting delivery of additional ventilators that are no longer required,” the HHS spokeswoman said.

There are nearly 120,000 ventilators available in the nation’s emergency reserves of medical supplies, which is “enough ventilators to meet maximum national capacity in a crisis,” according to the spokeswoman.

No shortages of the devices have been reported by hospitals or public health agencies treating people with COVID-19, the highly contagious disease that attacks the lungs.

Advertise with us

Philips Sleep and Respiratory Care has nearly 2,000 employees in five Western Pennsylvania locations. The final assembly and testing of the ventilators was done in Murrysville and at a second facility in Carlsbad, Calif.

A Philips spokesperson said Tuesday that it was too early to say what effect the end of the government contract would have on employment. “The COVID-19 pandemic is far from over and we continue to see solid demand for our products,” she said.

Kris B. Mamula: kmamula@post-gazette.com or 412-263-1699

This story was originally published with images that are no longer available.